JAPhA Practice Innovations最新文献

{"title":"Impact of pharmacist-led continuous glucose monitoring program on reduction in A1c in an FQHC","authors":"Makenzie Evers,&nbsp;Juanita Draime,&nbsp;Rachel Barhorst","doi":"10.1016/j.japhpi.2025.100039","DOIUrl":"10.1016/j.japhpi.2025.100039","url":null,"abstract":"<div><h3>Background</h3><div>Type 2 diabetes mellitus (T2DM) is a common disease affecting 37.3 million people in the United States. The use of continuous glucose monitors (CGMs) has been proven to improve patient glycemic outcomes and lower A1c. There is limited data available regarding the evaluation of personal CGMs in a pharmacist-led CGM management program.</div></div><div><h3>Objectives</h3><div>The primary objective of the study was to evaluate the effects of a pharmacist-led CGM management program in a Federally Qualified Health Center (FQHC). The secondary objective of the study was to assess the A1c reduction over time in a pharmacist-led CGM management program compared to the use of a CGM alone.</div></div><div><h3>Methods</h3><div>Family Health Services of Darke County is an FQHC in rural Ohio. Clinical pharmacists provide disease state management services for chronic disease states using a collaborative practice agreement (CPA). The CGM management program consists of uploading patient’s personal CGMs, interpreting the data, providing education, and utilizing a CPA to make therapeutic adjustments based on CGM data. A retrospective cohort analysis was performed. Patients with T2DM were included if they had a baseline A1c within 2 months of initiating a CGM, continued use of the CGM for at least 6 months, A1c measured at 3- or 4-month intervals, and at least one pharmacist-led appointment. Data collected included the date of CGM initiation, date of baseline A1c, baseline, and follow-up A1c readings, number of appointments, and number of medication interventions made by the clinical pharmacist.</div></div><div><h3>Results</h3><div>A significant reduction in A1c was observed in patients who participated in a pharmacist-led CGM management program.</div></div><div><h3>Conclusion</h3><div>This study demonstrated the impact that pharmacists can have on health outcomes when utilizing a CPA to provide individualized care.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 3","pages":"Article 100039"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Retrospective analysis of direct oral anticoagulation hold recommendation adherence for gastrointestinal procedures by an outpatient anticoagulation clinic","authors":"Allison L. Thurman,&nbsp;Aaron W. Brown,&nbsp;Christopher A. Knefelkamp,&nbsp;Sarah L. Hutfilz,&nbsp;Deanna S. Kania PharmD,&nbsp;Kristin S. Gaby","doi":"10.1016/j.japhpi.2025.100034","DOIUrl":"10.1016/j.japhpi.2025.100034","url":null,"abstract":"<div><h3>Background</h3><div>Anticoagulant medications can cause harm to patients in the periprocedural setting if managed inappropriately. Recent guidelines have attempted to standardize recommendations for anticoagulation management, but patients may still experience harm if these recommendations are not followed.</div></div><div><h3>Objectives</h3><div>This study aimed to compare the hold recommendations given by an outpatient anticoagulation clinic with the actual duration that patients held their anticoagulants periprocedurally. Additional outcomes included time between hold duration communication and procedure, significant bleeding events, thromboembolic events, and death within 30 days of the procedure.</div></div><div><h3>Methods</h3><div>This was a retrospective chart review of patients taking a direct oral anticoagulant (DOAC) who underwent an elective gastrointestinal procedure between April 30, 2021, and April 30, 2023. Data collection included adherence to periprocedural hold recommendations, length of time between communication of instructions and procedure, number of procedure cancellations or reschedules, and rates of 30-day bleeding events, thromboembolic events, and death.</div></div><div><h3>Results</h3><div>Two hundred charts were reviewed and 118 patients (59%) followed the preprocedure hold recommendations given by the anticoagulation clinic. The mean time between communicating recommendations to a patient and the date of the procedure was 56.6 days. No procedures were cancelled or rescheduled owing to DOAC mismanagement. There were 5 bleeding events and no clotting events or deaths within 30 days of the procedure. Of the patients who experienced a bleeding event, none held their anticoagulant for a shorter duration than recommended.</div></div><div><h3>Conclusion</h3><div>This study revealed nonideal patient adherence to guideline-based periprocedural hold recommendations for DOACs. Despite this, no procedures were delayed or cancelled, and limited safety events occurred. The length of time between communication of the recommendation and the date of the procedure was long and may explain low patient adherence. Additional studies are necessary to determine periprocedural adherence and potential adverse outcomes for other surgical procedures.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 3","pages":"Article 100034"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Implementation of pharmacist-initiated proton pump inhibitor deprescribing for ambulatory care patients","authors":"Sehara Hill,&nbsp;Marissa Egipciaco,&nbsp;Tina Tidwell","doi":"10.1016/j.japhpi.2025.100037","DOIUrl":"10.1016/j.japhpi.2025.100037","url":null,"abstract":"<div><h3>Background</h3><div>The 2022 American Gastroenterological Association Proton Pump Inhibitor (PPI) Deprescribing Clinical Guidelines recommend regular review of patients prescribed PPI therapy; however, this may be limited due to insufficient provider time and resources. This evaluation aimed to assess the impact of pharmacist-initiated PPI deprescribing interventions for ambulatory care patients.</div></div><div><h3>Objectives</h3><div>The objectives of this evaluation were to describe (a) PPI deprescribing interventions defined as PPI discontinuation or de-escalation of dose by Veterans Affairs clinical pharmacists in the outpatient setting; (b) the percentage of appropriate indications documented within the electronic medical record for high-dose PPI therapy; (c) the percentage of PPI deprescribing success at 3-week follow-up and 1-year follow-up; and (d) estimated total cost savings annually.</div></div><div><h3>Methods</h3><div>This was a single-centered, quality improvement, evaluation that utilized a patient monitoring tool dashboard to identify ambulatory patients with an active outpatient prescription for high-dose PPI therapy. Inclusion criteria included adult patients without an indication for long-term PPI therapy. Pharmacists contacted eligible patients to assess interest in PPI deprescribing via implementation of a shared decision-making intervention(s) based on an approved institution-specific algorithm.</div></div><div><h3>Results</h3><div>Of the 50 patients eligible for PPI deprescribing, 33 (66%) were agreeable to PPI deprescribing interventions. In patients without an indication, pharmacist intervention led to 25 indications being added to the electronic health record. PPI deprescribing success at the 3-week follow-up occurred in 27 patients (82%) of patients. A 1-year follow-up was conducted with 91% deprescribing interventions sustained and an estimated total cost savings of $58,919.90 annually.</div></div><div><h3>Conclusion</h3><div>A pharmacist-initiated shared decision model demonstrated sustained outcomes in PPI deprescribing. Overall, this evaluation provided data to support pharmacist deprescribing interventions as an effective way to minimize inappropriate continuation of high-dose PPI therapy. Further research is warranted to determine the long-term feasibility, sustainability, and safety benefits.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 3","pages":"Article 100037"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Deprescribing sulfonylureas in patients over the age of 65 within the Boise VA Medical Center","authors":"Natalie Everett,&nbsp;Robyn Cruz,&nbsp;Leanne Ertle,&nbsp;Elaine Nguyen","doi":"10.1016/j.japhpi.2025.100051","DOIUrl":"10.1016/j.japhpi.2025.100051","url":null,"abstract":"<div><h3>Background</h3><div>There are hypoglycemia-related safety concerns with sulfonylureas, especially in older adults with type 2 diabetes mellitus (T2DM). Clinical pharmacist practitioners working in primary care clinics have the opportunity to address these concerns and potentially optimize patients’ diabetes medication regimens through deprescribing of potentially unsafe sulfonylureas.</div></div><div><h3>Objective</h3><div>This study aimed to assess the impact of a pharmacist-led sulfonylurea deprescribing campaign in older adults with T2DM in the primary care setting of a Veterans Affairs medical center.</div></div><div><h3>Methods</h3><div>This was a prospective sulfonylurea deprescribing campaign conducted over a period of approximately 5 months at a single institution. Patients were enrolled if they were older than 65 years with an active sulfonylurea prescription, had an A1c of less than 8%, and were on select primary care teams. The primary project evaluator telephoned eligible patients to invite them to participate in a sulfonylurea deprescribing initiative, with those accepting then receiving a scheduled call to deprescribe their therapy and at least 1 subsequent follow-up call to assess changes in blood glucose. The primary end point was the percentage of patients successfully deprescribed from sulfonylurea therapy. Secondary end points were the number of patients requiring diabetes therapy adjustment and the number of follow-up visits required to optimize antidiabetic medications after sulfonylurea discontinuation.</div></div><div><h3>Results</h3><div>Nineteen patients received the sulfonylurea deprescribing intervention. Of these patients, 11 were able to successfully discontinue therapy with 3 of these patients requiring additional antidiabetic medication adjustments. Nine patients who received the intervention needed only 1 follow-up visit. At the time of data collection, 4 patients were still undergoing therapy adjustments after their initial sulfonylurea discontinuation.</div></div><div><h3>Conclusion</h3><div>This pharmacist-led sulfonylurea deprescribing campaign was successful. However, it did require substantial pharmacist involvement with some patients needing extended follow-up.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 3","pages":"Article 100051"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of a pharmacist-led smoking cessation service on changes in patients’ attitudes toward smoking","authors":"Hayley Wells,&nbsp;Sara McEntee,&nbsp;Yifei Liu","doi":"10.1016/j.japhpi.2025.100028","DOIUrl":"10.1016/j.japhpi.2025.100028","url":null,"abstract":"<div><h3>Objectives</h3><div>This study aimed to examine the impact of a community pharmacist-led smoking cessation service on changes in patients’ attitudes toward smoking, nicotine replacement therapy (NRT) utilization, and rates of tobacco cessation.</div></div><div><h3>Methods</h3><div>Between September 2023 and February 2024, 1 chain community pharmacy located within a health system enrolled people aged 18 years and older who were interested in quitting tobacco cigarettes in a biweekly telephone-based program that provided behavioral support and NRT. Participants completed the Attitude Towards Smoking Scale (ATS-18) before and after the intervention. Paired <em>t</em> tests were conducted to examine changes in patients’ perceptions using the ATS-18. Participants self-reported barriers to NRT before the intervention. Fisher’s exact tests were conducted to examine the relationship between participants who reported previous barriers to NRT use and those who agreed to use NRT. The number of participants who quit smoking was also reported.</div></div><div><h3>Results</h3><div>A total of 71 participants were enrolled in the study, of whom 40 (56.3%) completed the study. Only participants who completed the study were analyzed because those who dropped out did not complete the ATS-18 after the intervention and their changes in attitudes could not be assessed. Participants had a mean age of 59 years, 52% were male, and 59% were African American. Participants reported positive changes in their perceptions of tobacco cessation based on the ATS-18 (<em>P</em> &lt; 0.001). Furthermore, 33 participants agreed to use and pick up NRT and 11 participants self-reported smoking cessation.</div></div><div><h3>Conclusion</h3><div>A pharmacist-led smoking cessation service positively affected patients’ attitudes toward smoking.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 3","pages":"Article 100028"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of a pharmacist-led stewardship intervention for antibiotic prescribing in the emergency department","authors":"Emily A. Plauche,&nbsp;Kayla R. Stover,&nbsp;Katie E. Barber,&nbsp;David A. Cretella,&nbsp;Mary Joyce B. Wingler","doi":"10.1016/j.japhpi.2025.100040","DOIUrl":"10.1016/j.japhpi.2025.100040","url":null,"abstract":"<div><h3>Background</h3><div>Antibiotics are commonly prescribed in emergency departments but limited studies have been published describing antimicrobial stewardship interventions in this practice area. The purpose of this study was to assess the effectiveness of a multifaceted pharmacist-led antimicrobial stewardship intervention on selection and duration of antibiotics prescribed in the emergency department.</div></div><div><h3>Methods</h3><div>This single-center, quasi-experimental study evaluated patients discharged from the adult emergency department between October 1, 2021 to February 28, 2022 (preintervention group) and October 1, 2022 to February 28, 2023 (postintervention). Antibiotic default durations were removed from the electronic medical record in September 2022, and education was provided to emergency department prescribers on proper antibiotic selection and duration. Adult patients with a new presumed diagnosis of acute cystitis, acute pyelonephritis, community-acquired pneumonia (CAP), cellulitis, or skin abscess with a new prescription for an oral antibiotic at emergency department discharge were included. The primary outcome was the duration of antibiotic therapy prescribed.</div></div><div><h3>Results</h3><div>There were 220 patients included (110 preintervention; 110 postintervention). Baseline characteristics were similar between groups, and acute cystitis (45%) was the most common indication. The mean antibiotic duration was low in both groups, and there was no statistically significant difference between pre- and postgroups (6.60 vs. 6.35 days; <em>P</em> = 0.382). A 10% decrease in antibiotic inappropriateness was found in the preintervention to postintervention groups (<em>P</em> = 0.075).</div></div><div><h3>Conclusion</h3><div>Overall duration was lower than expected in the pre- and postgroups, with most patients receiving less than 7 days of antibiotics for multiple common infections. Several challenges were identified for performing stewardship in the emergency departments and further interventions have been planned based on the results of this study.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 3","pages":"Article 100040"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Expanding horizons: Resident research makes its debut in JAPhA Practice Innovations","authors":"Darin C. Ramsey PharmD, BCPS, BCACP","doi":"10.1016/j.japhpi.2025.100054","DOIUrl":"10.1016/j.japhpi.2025.100054","url":null,"abstract":"","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 3","pages":"Article 100054"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Determining patient motivators to receiving the respiratory syncytial virus vaccine in the community pharmacy setting","authors":"Sarah Stetzer,&nbsp;Cherokee Layson-Wolf,&nbsp;Hyunuk Seung,&nbsp;Eric Kim,&nbsp;Vicki Bulkin,&nbsp;Deanna Tran","doi":"10.1016/j.japhpi.2025.100036","DOIUrl":"10.1016/j.japhpi.2025.100036","url":null,"abstract":"<div><h3>Background</h3><div>A single respiratory syncytial virus (RSV) vaccine dose is indicated for all adults 75 years of age and older and adults 60 to 74 years of age if they are at an increased risk of severe RSV disease. It is important for community pharmacists to understand which marketing methods are the key motivators for patients to receive the RSV vaccine given that they are among the most accessible health care professionals.</div></div><div><h3>Objectives</h3><div>The primary objective is to determine which marketing methods are the main factors that affect patients’ decisions to receive the RSV vaccine. The secondary objective is to determine which marketing methods influence certain demographics of patients.</div></div><div><h3>Methods</h3><div>An anonymous, 8-item survey was administered to individuals and data collection occurred from December 2023 to March 2024. The survey collected information about participants’ comorbidities, how participants heard about the RSV vaccine, what marketing tactics were most influential in their decision to receive the RSV vaccine, and other nonmarketing factors that may have motivated participants.</div></div><div><h3>Results</h3><div>Forty-eight surveys were collected and analyzed. More than half of the participants did not report any comorbid conditions (52.1%). The most frequently reported comorbid conditions were diabetes (25%) and chronic lung disease (18.8%). Television, commercials or news (62.5%), and primary care providers (54.2%) were selected as the 2 most frequently reported ways participants had heard about the RSV vaccine. Of all the available marketing methods provided, participants chose primary care providers (41.7%) as having the most influence on their decision to get the RSV vaccine.</div></div><div><h3>Conclusion</h3><div>These findings give insight into which marketing methods are more likely to influence patients to receive the RSV vaccine. Primary care providers were found to be the primary motivators for participants to receive the RSV vaccine. This study reinforces the importance of community pharmacists’ partnerships with providers to help increase access to information and receipt of RSV vaccination.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 3","pages":"Article 100036"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Identifying barriers and facilitators to pharmacist-dietitian collaboration to optimize patient health: A focus group study","authors":"Daniel Hough,&nbsp;James Knight,&nbsp;Kimberlee Kilgore Meade,&nbsp;Christopher Pegg,&nbsp;Andrew Beard,&nbsp;Leanne J. Rein,&nbsp;Kenneth C. Hohmeier","doi":"10.1016/j.japhpi.2025.100052","DOIUrl":"10.1016/j.japhpi.2025.100052","url":null,"abstract":"<div><h3>Objective</h3><div>This study aimed to identify barriers and facilitators to pharmacist-dietitian collaboration by identifying behavioral themes using the COM-B model.</div></div><div><h3>Design</h3><div>This was a qualitative research study using focus groups.</div></div><div><h3>Setting and participants</h3><div>The study was conducted at a single region of a nationwide supermarket pharmacy chain. Focus group participants were pharmacists employed by the pharmacy.</div></div><div><h3>Outcome measures</h3><div>The COM-B model was used to develop questions for the focus group guide. The focus group covered topics such as pharmacists’ knowledge of dietitian services, patient identification and referral processes, medical conditions, workflow integration, time and impact on workflow, pharmacists’ perceived patient reactions, service costs, incentives, general thoughts on referrals, potential benefits and concerns, and demographic information focus group sessions were recorded, transcribed, and analyzed using a rapid analysis technique to categorize text segments using COM-B model domains.</div></div><div><h3>Results</h3><div>A total of 3 focus groups containing 4-5 pharmacists each were completed. Three themes were identified from the rapid analysis: theme 1, knowledgeability of dietary program and motivation to refer; theme 2, barriers and perceptions by pharmacists related to the dietary service; and theme 3, gaps in communication and collaboration.</div></div><div><h3>Conclusion</h3><div>There were several identified barriers and facilitators to improving pharmacist-dietitian collaboration. Future research is needed to explore how best to address these barriers and facilitators to scale collaboration.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 3","pages":"Article 100052"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluating the impact of pharmacist-delivered educational intervention on the willingness to receive HPV vaccine in a dental clinic in New York","authors":"Julian Azzouzi ,&nbsp;Joanne Son ,&nbsp;Katrin Tamari ,&nbsp;Eric Wachs ,&nbsp;Elizabeth J. Unni","doi":"10.1016/j.japhpi.2025.100053","DOIUrl":"10.1016/j.japhpi.2025.100053","url":null,"abstract":"<div><h3>Background</h3><div>Human papillomavirus (HPV) infections are the leading cause of oral and oropharyngeal cancers in the United States, accounting for 70% of new diagnoses. An estimated 90% of newly diagnosed HPV-attributed cancer cases could be preventable with HPV vaccination before exposure, given that the vaccine is 100% effective for at least 12 years. Collaboration between dentists and pharmacists to enhance patient-centered care and vaccine education holds considerable potential to increase HPV vaccine rates among persons aged 9-26 years. Current literature exploring interprofessional collaboration between dentists and pharmacists suggests this partnership may address gaps in patient care, although examples of HPV vaccine initiatives are limited.</div></div><div><h3>Objective</h3><div>This study aimed to assess the impact of screening dental patients’ HPV vaccine status and providing pharmacist-led education and counseling on the intent of patients or guardians to receive the HPV vaccine.</div></div><div><h3>Methods</h3><div>Approved by the institutional review board, a cross-sectional prospective review of patients was conducted at a dental clinic. Patients aged 18-26 years and those aged 9-17 with consenting guardians who had not received the HPV vaccine, verified via the New York State Immunization Information System, were included. Enrolled participants received pharmacist-led education and counseling on HPV and the vaccine, including an educational handout. After the intervention, participants were surveyed to assess their interest in receiving the HPV vaccine. Statistical analysis used a 1-sample proportion test.</div></div><div><h3>Results</h3><div>A total of 67 patients and guardians were approached after prospective review, 32 agreed to participate, 13 were excluded, and a total of 19 were enrolled in the study. After pharmacist intervention, the proportion of participants’ intent to receive the HPV vaccine was 0.895 (<em>P</em> &lt; .001; 95% CI, 0.76–1.00).</div></div><div><h3>Conclusion</h3><div>Screening dental patients’ HPV vaccine status, paired with pharmacist-delivered HPV education and HPV vaccine counseling, may positively affect unvaccinated patients’ or guardians’ intent to receive the HPV vaccine.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 3","pages":"Article 100053"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144631588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}